lisbell dianne estrada apablaza
Decana Facultad Ciencias de la Salud
Universidad Bernardo O Higgins
santiago, Chile
Alzheimer disease; Protein misfolding; Molecular and cell Biology
-
Ciencias mención Biología, UNIVERSIDAD DE CHILE. Chile, 2010
-
Ingeniero en Biotecnologia Molecular, UNIVERSIDAD DE CHILE. Chile, 2005
-
Directora de Investigacion y Doctorados Full Time
UNIVERSIDAD BERNARDO O'HIGGINS
Salud
santiago, Chile
2015 - 2019
-
Investigador Asociado Full Time
PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE
Ciencias Biológicas
Santiago, Chile
2010 - 2015
-
Decana Full Time
UNIVERSIDAD BERNARDO O'HIGGINS
Ciencias de la Salud
Santiago, Chile
2020 - At present
-
research associate Full Time
University of texas medical branch
Galveston, Estados Unidos
2003 - 2008
2016-Tesista de Pregrado Universidad Bernardo O Higgins. Srta. Nicole Mundaca. Fondecyt 11130561.
2017-Tesista de Pregrado Universidad Bernardo O Higgins. Sr. Pablo Ahumada. Fondecyt 11130561.
2017-Tesista de Postgrado Programa Magister en Ciencias Químico-Biológicas Universidad Bernardo O Higgins. Srta. Elizabeth Durán. Fondecyt 11130561.
2018-Tesista de Postgrado Programa Magister en Ciencias Químico-Biológicas Universidad Bernardo O Higgins. Srta. Elena Castañeda. Fondecyt 11130561.
2019-Tesista de Postgrado Programa Magister en Ciencias Químico-Biológicas Universidad Bernardo O Higgins. Sr. Pablo Ahumada Fondecyt 11130561.
2019-Tesista de Postgrado (en curso) Programa Magister en Ciencias Químico-Biológicas Universidad Bernardo O Higgins. Sr. Luis Astete.
2019-Tesista de Postgrado (en curso) Programa Magister en Ciencias Químico-Biológicas Universidad Bernardo O Higgins. Srta. María Celis.
Oxidative Stress in Disease and Aging: Mechanisms and Therapies 2018 |
BLOOD BRAIN BARRIER INSIGHTS=> PATHOLOGICAL BREAKDOWN AND MODULATION AS A THERAPEUTIC APPROACH FOR ALZHEIMER´S DISEASE |
Centro de envejecimiento y regeneracion CARE |
Identification of c-Abl inhibitors for the potential treatment of Alzheimer disease |
Uncovering the mechanisms of Amyloid clearence induced by STI571-treatment in Alzheimers disease=> the role of the Abl kinase |
Development of Blood biomarkers for early diagnosis and to track progression of Alzheimers disease |
Detection of misfolded Aß oligomers for early diagnosis of Alzheimer’s diseases |
Small molecule ß-sheet breaker peptidemimetics for Alzheimer’s therapy |
Smoking and amyloid formation in Alzheimer’s disease |
Liver Dysfunction as a Novel Player in Alzheimer's Progression: Looking Outside the Brain |
TGF-? and hepatocellular carcinoma: When a friend becomes an enemy |
Protein misfolding and neurodegeneration |